Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 4 of the 13 calendar months from Oct 2025 to Oct 2026: Mar 2026, Jun 2026, Sep 2026 and Oct 2026.
- Largest single sale: $5.8M (63,596 shares) of Oruka Therapeutics, Inc. on Sep 1, 2026. Filing
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | Chief Executive Officer, Director | Sep 6, 2024 | Oct 2, 2026 |
| Dyne Therapeutics, Inc. (DYN) | Former Director | Sep 16, 2020 | Jul 6, 2022 |
Also a director at
Dyne Therapeutics, Inc. (DYN) (no filing in the last 18 months)
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Oct 1, 2026, Oruka Therapeutics, Inc.: sold 25,000 shares for $2.1M, under a disclosed plan; 25,000 shares acquired by exercising options. 1 filing: 1
- Sep 15, 2026, Oruka Therapeutics, Inc.: sold 2,452 shares for $235K, to cover taxes. 1 filing: 1
- Sep 1, 2026, Oruka Therapeutics, Inc.: sold 75,000 shares for $6.9M, under a disclosed plan; 75,000 shares acquired by exercising options. 1 filing: 1
- Jun 15, 2026, Oruka Therapeutics, Inc.: sold 1,729 shares for $120K, to cover taxes. 1 filing: 1
- Mar 16, 2026, Oruka Therapeutics, Inc.: sold 1,729 shares for $71K, to cover taxes. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.